SRL Diagnostics poised for growth after Manipal Enterprises picks 20% stake

SRL, which draws 16% of its revenue from Fortis Healthcare, is set to gain from the merger with Manipal Hospitals

Even as American investment company TPG Capital-backed Manipal Health Enterprises picks up a 20 per cent stake in India's largest diagnostic chain SRL Diagnostics, and is working to acquire a majority stake in the entity, analysts point out that SRL is aiming to grow at a 15 per cent compound annual rate (CAGR) over the medium term.

SRL, which draws 16 per cent of its revenue from Fortis Healthcare, is set to gain from the merger with Manipal Hospitals, in a deal that makes the combined entity the largest corporate hospital chain in the country.

SRL has grown at a 14 per